MSI Financial Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

MSI Financial Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$184K	Sell	4,706 -2,836	-38%	-$115K	0.01%	1129
2016 Q3	$333K	Sell	7,542 -2,235	-23%	-$101K	0.01%	838
2016 Q2	$409K	Buy	9,777 +37	+0.4%	+$1.57K	0.01%	718
2016 Q1	$392K	Sell	9,740 -15,989	-62%	-$677K	0.02%	693
2015 Q4	$1.32M	Buy	25,729 +6,570	+34%	+$335K	0.06%	303
2015 Q3	$899K	Buy	19,159 +1,615	+9%	+$97.3K	0.07%	271
2015 Q2	$1.09M	Sell	17,544 -1,388	-7%	-$86.5K	0.08%	273
2015 Q1	$1.17M	Buy	+18,932	New	+$1.12M	0.08%	269
2014 Q4	–	Sell	-15,246	Closed	-$808K	–	2800
2014 Q3	$808K	Buy	15,246 +3,508	+30%	+$178K	0.1%	250
2014 Q2	$609K	Buy	11,738 +1,328	+13%	+$64K	0.08%	286
2014 Q1	$487K	Buy	10,410 +2,610	+33%	+$123K	0.07%	307
2013 Q4	$343K	Buy	7,800 +36	+0.5%	+$1.5K	0.05%	364
2013 Q3	$299K	Buy	7,764 +198	+3%	+$7.49K	0.05%	343
2013 Q2	$267K	Buy	+7,566	New	+$255K	0.05%	341

Other funds holding XPH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

MSI Financial Services's XPH Position: Q4 2016 in Review

MSI Financial Services reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 38% in Q4 2016, selling an estimated $115K and leaving 4,706 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #1129.

MSI Financial Services first reported a position in XPH in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.32M in Q4 2015. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2016.

MSI Financial Services held 4,706 shares of State Street SPDR S&P Pharmaceuticals ETF worth $184K as of Q4 2016.
MSI Financial Services sold 2,836 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2016, an estimated $115K.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of MSI Financial Services's portfolio in Q4 2016, its #1129 holding.
MSI Financial Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 14 quarters since.
MSI Financial Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.32M in Q4 2015.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.